3 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Bottom 1%
#5326 out of 5334 analysts
Average Return
-14.67%
Win Rate
30%86 out of 288
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-03 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-24 - 2024-11-22 | Buy |
Aim Immunotech IncAIM | +583.49% | $0.22 | $1.49 | 2024-12-10 - 2025-12-09 | Buy |
Quantum Computing IncQUBT | +318.80% | $2.66 | $11.14 | 2024-11-13 - 2025-11-12 | Buy |
Duos Technologies Group IncDUOT | +234.24% | $2.57 | $8.59 | 2024-06-07 - 2025-06-06 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Quantum Computing IncQUBT | 7 | Buy | $30.00 | +303.77% | Maintains | a month ago |
Knightscope IncKSCP | 7 | Buy | $23.00 | +1,486.21% | Maintains | a month ago |
Duos Technologies Group IncDUOT | 10 | Buy | $22.00 | +172.61% | Maintains | a month ago |
Outlook Therapeutics IncOTLK | 8 | Buy | $10.00 | +611.74% | Maintains | 2 months ago |
Aytu Biopharma IncAYTU | 4 | Buy | $14.50 | +571.30% | Maintains | 2 months ago |
Synergy Chc CorpSNYR | 3 | Buy | $3.75 | +2,092.98% | Maintains | 2 months ago |
Surgepays IncSURG | 11 | Buy | $3.50 | +1,352.28% | Maintains | 2 months ago |
Banzai International IncBNZI | 9 | Buy | $42.00 | +1,809.09% | Maintains | 2 months ago |
Nexttrip IncNTRP | 2 | Buy | $7.50 | +328.57% | Maintains | 2 months ago |
Pavmed IncPAVM | 10 | Buy | $56.00 | +1,081.43% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 10 | Buy | $9.25 | +918.72% | Maintains | 2 months ago |
Myomo IncMYO | 7 | Buy | $10.00 | +930.93% | Maintains | 2 months ago |
Plus Therapeutics IncPSTV | 8 | Buy | $57.00 | +1,388.25% | Maintains | 2 months ago |
Allarity Therapeutics IncALLR | 5 | Buy | $10.25 | +761.34% | Maintains | 2 months ago |
Intrusion IncINTZ | 8 | Buy | $9.50 | +1,166.67% | Maintains | 2 months ago |
Cingulate IncCING | 6 | Buy | $52.00 | +1,020.69% | Maintains | 2 months ago |
Igc Pharma IncIGC | 10 | Buy | $5.50 | +1,983.33% | Maintains | 2 months ago |
Genasys IncGNSS | 7 | Buy | $6.00 | +261.45% | Maintains | 2 months ago |
Gri Bio IncGRI | 7 | Buy | $32.00 | +2,106.90% | Maintains | 2 months ago |
Renovorx IncRNXT | 10 | Buy | $14.00 | +1,518.50% | Maintains | 2 months ago |
Endra Life Sciences IncNDRA | 6 | Buy | $25.00 | +414.40% | Maintains | 2 months ago |
Aim Immunotech IncAIM | 6 | Buy | $9.00 | +3,514.46% | Maintains | 2 months ago |
TravelzooTZOO | 7 | Buy | $23.00 | +129.43% | Maintains | 2 months ago |
Aemetis IncAMTX | 7 | Buy | $22.00 | +1,205.64% | Maintains | 2 months ago |
Pro Dex IncPDEX | 5 | Buy | $70.00 | +27.43% | Maintains | 3 months ago |
Nrx Pharmaceuticals IncNRXP | 8 | Buy | $49.00 | +1,206.67% | Maintains | 3 months ago |
Maison Solutions IncMSS | 4 | Buy | $162.50 | +8,731.52% | Maintains | 3 months ago |
Atossa Therapeutics IncATOS | 8 | Buy | $24.00 | +945.75% | Maintains | 4 months ago |
Sintx Technologies IncSINT | 5 | Buy | $12.00 | +757.14% | Maintains | 4 months ago |
Alzamend Neuro IncALZN | 7 | Buy | $28.00 | +2,005.26% | Maintains | 7 months ago |
Society Pass IncorporatedSOPAQ | 7 | Buy | $22.50 | +29,505.26% | Maintains | 7 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | N/A | Maintains | a year ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | N/A | Maintains | a year ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | N/A | Maintains | a year ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | N/A | Maintains | a year ago |
Groupon IncGRPN | 8 | Buy | $19.00 | N/A | Maintains | a year ago |
Daxor CorpDXR | 3 | Buy | $25.00 | N/A | Maintains | a year ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | N/A | Maintains | a year ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | N/A | Maintains | a year ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 2 years ago |
Booking Holdings IncBKNG | 2 | Buy | $97,500.00 | N/A | Maintains | 3 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 3 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 3 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 3 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 4 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 4 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 4 years ago |
Realloys IncALOY | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Stablecoin Development CorpSDEV | 3 | Buy | $24,500.00 | N/A | Maintains | 4 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 5 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 5 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.